Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News on Pharma

Trump administration’s embattled FDA vaccine chief departing for the second time

Vinay Prasad to leave in April after decisions involving vaccine reviews and specialty drugs for rare diseases

The Guardian - US

Navjot, Attarvir, Balwinder and Manpreet Singh charged after $2.3 million in suspected fentanyl seized in Brampton

Police have charged four men and seized more than $2.3 million worth of suspected fentanyl as part of a major drug trafficking investigation that stretched from the Greater Toronto Area to Alberta.

The Times of India

Emma Walmsley’s pay rose almost 50% to £15.6m in final year as GSK boss

Bulk of 2025 renumeration came from share bonuses as drug company’s now former CEO benefitted from stock rise

The Guardian - UK

From analysis to the latest developments in health,
read the most diverse news in one place.

CVS warns it could close all 134 locations in a single state if new bill goes ahead

A spokesperson for CVS Health slammed the proposal, branding it ‘bad for Tennessee’

The Independent UK

Novartis settles with Henrietta Lacks' estate over use of her 'stolen' cells to advance medicine

Novartis has settled a lawsuit by the estate of Henrietta Lacks that alleged the pharmaceutical giant unjustly profited off her cells, which were taken from her tumor without her knowledge in 1951 and reproduced in labs to enable major medical advancements, including the polio vaccine

The Independent UK

FDA to offer bonus payments to staffers who complete speedy drug reviews

The head of the Food and Drug Administration plans to start offering bonus payments to agency drug reviewers who complete their work ahead of the schedule

The Independent UK

UAE urgently recalls 4 health products: What every consumer must know

UAE health authorities have urgently recalled four products, including three supplements and one medical item, due to serious safety concerns like unapproved ingredients and contamination. Consumers are warned against purchasing or using these. The recall of the supplements and health product highlights the nation's commitment to public health and strict…

The Times of India

Read news from The Economist, FT, and more,
with one subscription

Novo Nordisk announces plan to cut Ozempic and Wegovy prices up to 50 percent

One in eight Americans are taking weight loss drugs like Ozempic and Wegovy

The Independent UK

AstraZeneca boss Pascal Soriot’s pay rises to £17.7m

Increase of 6.4% comes as drugmaker reports strong profit growth, despite cancelling UK investment projects

The Guardian - UK

UAE announces new pharmaceutical rule to break medicine monopolies and lower drug costs

UAE residents will find essential medicines more accessible and affordable following a landmark reform by the Emirates Drug Establishment. Effective February 24, 2026, a new rule mandates multiple authorized agents for each drug, dismantling single-agent monopolies. This move enhances supply chain flexibility, boosts competition, and strengthens the nation's healthcare sector.

The Times of India

The biggest challenge to Trump's drug price claims? Reality

It's unclear how many patients will actually pay less under Trump's "most favored nation" deals.

Axios

FDA proposes new system for approving customized drugs and therapies for rare diseases

The Food and Drug Administration is proposing a system for approving customized drugs and medical treatments for patients with rare or hard-to-treat diseases

The Independent UK

Wegovy and Ozempic owner dealt blow as next-gen weight-loss drug is labelled ‘obsolete’

Novo Nordisk’s shares fall sharply after testing of CagriSema falls short of investors’ expectations

The Guardian - UK

Warning as major shortage of painkiller used by millions could last until summer

The National Pharmacy Association (NPA) has warned the shortage could last until at least June

The Independent UK

Get all your
news in one place.

100's of premium titles.
One news app.

AAP

Biotech giant's shares dive after CEO's shock departure

Shares in Australia's largest biopharmaceutical company have hit an eight-year low after the sudden retirement of its chief executive.

The Guardian - UK

AstraZeneca CEO hails NHS drug price deal but keeps pause on £200m UK investment

Pascal Soriot suggests UK-US agreement will not be enough to revive plan to expand Cambridge site

Axios

How TrumpRx drug prices compare to generic alternatives

Patients could save more buying non-branded copycat drugs, even if they don't have insurance.

The Times of India

‘You’ll save a fortune’: What is TrumpRx? All about Trump’s online drugstore plan

US President Trump's new TrumpRx website is rolling out, aiming to slash prescription drug costs by getting them straight from manufacturers. They're promising big savings on popular meds like weight-loss and fertility treatments, using a 'most favoured nation' pricing strategy. This is all about making healthcare more affordable for Americans,…

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Hims & Hers launches copy of Wegovy pill, prompting legal threats from drugmaker Novo Nordisk

Telehealth company Hims & Hers is launching a cheaper, off-brand version of the blockbuster weight loss pill Wegovy

The Independent UK

The new ‘blue pill’: Honey energy supplement under recall for having ED medicine mixed in

The affected ED drug may cause heart issues, blood pressure changes, dizziness and headaches, particularly in people with health conditions or taking certain medications

The Guardian - UK

GSK, take two: the bullish tone at the top is finally more convincing

New boss Luke Miels knows perils of overpromising but there is growing sense pharma firm is closer to filling potential

The Guardian - UK

Wegovy and Ozempic maker forecasts sharp drop in revenue for 2026

Novo Nordisk share price plunges after blaming lower US drug prices, patent protection issues and rising competition

The Guardian - UK

AstraZeneca to invest £11bn in China after rowing back on UK expansion

Keir Starmer says the move, announced during his trip to Beijing, will help support thousands of British jobs

The Independent UK

Altria earnings fall short amid lower cigarette sales and competition for nicotine products

Shares of Altria dipped Thursday after the tobacco giant reported flat earnings due to declining cigarettes sales and challenging competition for newer products, including flavored nicotine pouches

International Business Times

NovaDerm and Solidaris Capital: How Selective Narratives Obscure Regulatory Evasion and Charitable Tax Misuse

Solidaris markets itself as a socially responsible investment platform promising large deductions, but public records and whistleblower reports reveal significant operational discrepancies.

1 … 3 4 5 6

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

347 stories

Agency

287 stories

the Food and Drug Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.